135 related articles for article (PubMed ID: 37734846)
21. More than meets the eye: The evolving phenotype of Weill-Marchesani syndrome-diagnostic confusion with geleophysic dysplasia.
Pimienta AL; Wilcox WR; Reinstein E
Am J Med Genet A; 2013 Dec; 161A(12):3126-9. PubMed ID: 24039088
[TBL] [Abstract][Full Text] [Related]
22. A Pedigree Report of a Rare Case of Weill-Marchesani Syndrome with New Compound Heterozygous LTBP2 Mutations.
Lin Z; Zhu M; Deng H
Risk Manag Healthc Policy; 2021; 14():1785-1789. PubMed ID: 33958902
[TBL] [Abstract][Full Text] [Related]
23. Novel homozygous
Miao N; Zhang Y; Liao JY; Zhou L; He JC; Yang RQ; Liu XY; Tang L
Int J Ophthalmol; 2023; 16(5):694-699. PubMed ID: 37206179
[TBL] [Abstract][Full Text] [Related]
24. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome.
Faivre L; Dollfus H; Lyonnet S; Alembik Y; Mégarbané A; Samples J; Gorlin RJ; Alswaid A; Feingold J; Le Merrer M; Munnich A; Cormier-Daire V
Am J Med Genet A; 2003 Dec; 123A(2):204-7. PubMed ID: 14598350
[TBL] [Abstract][Full Text] [Related]
25. Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions.
Cain SA; McGovern A; Baldwin AK; Baldock C; Kielty CM
PLoS One; 2012; 7(11):e48634. PubMed ID: 23133647
[TBL] [Abstract][Full Text] [Related]
26. Acromelic dysplasias: how rare musculoskeletal disorders reveal biological functions of extracellular matrix proteins.
Stanley S; Balic Z; Hubmacher D
Ann N Y Acad Sci; 2021 Apr; 1490(1):57-76. PubMed ID: 32880985
[TBL] [Abstract][Full Text] [Related]
27. Familial spherophakia with short stature caused by a novel homozygous ADAMTS17 mutation.
Khan AO; Aldahmesh MA; Al-Ghadeer H; Mohamed JY; Alkuraya FS
Ophthalmic Genet; 2012 Dec; 33(4):235-9. PubMed ID: 22486325
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS10-mediated tissue disruption in Weill-Marchesani syndrome.
Mularczyk EJ; Singh M; Godwin ARF; Galli F; Humphreys N; Adamson AD; Mironov A; Cain SA; Sengle G; Boot-Handford RP; Cossu G; Kielty CM; Baldock C
Hum Mol Genet; 2018 Nov; 27(21):3675-3687. PubMed ID: 30060141
[TBL] [Abstract][Full Text] [Related]
29. From tall to short: the role of TGFβ signaling in growth and its disorders.
Le Goff C; Cormier-Daire V
Am J Med Genet C Semin Med Genet; 2012 Aug; 160C(3):145-53. PubMed ID: 22791552
[TBL] [Abstract][Full Text] [Related]
30. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.
Sakai LY; Keene DR; Renard M; De Backer J
Gene; 2016 Oct; 591(1):279-291. PubMed ID: 27437668
[TBL] [Abstract][Full Text] [Related]
31. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome.
Faivre L; Gorlin RJ; Wirtz MK; Godfrey M; Dagoneau N; Samples JR; Le Merrer M; Collod-Beroud G; Boileau C; Munnich A; Cormier-Daire V
J Med Genet; 2003 Jan; 40(1):34-6. PubMed ID: 12525539
[TBL] [Abstract][Full Text] [Related]
32. Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway.
Oichi T; Taniguchi Y; Soma K; Oshima Y; Yano F; Mori Y; Chijimatsu R; Kim-Kaneyama JR; Tanaka S; Saito T
Cell Mol Life Sci; 2019 Dec; 76(23):4795-4809. PubMed ID: 31201465
[TBL] [Abstract][Full Text] [Related]
33. Identification and molecular characterisation of a homozygous missense mutation in the ADAMTS10 gene in a patient with Weill-Marchesani syndrome.
Steinkellner H; Etzler J; Gogoll L; Neesen J; Stifter E; Brandau O; Laccone F
Eur J Hum Genet; 2015 Sep; 23(9):1186-91. PubMed ID: 25469541
[TBL] [Abstract][Full Text] [Related]
34. Weill-Marchesani syndrome--possible linkage of the autosomal dominant form to 15q21.1.
Wirtz MK; Samples JR; Kramer PL; Rust K; Yount J; Acott TS; Koler RD; Cisler J; Jahed A; Gorlin RJ; Godfrey M
Am J Med Genet; 1996 Oct; 65(1):68-75. PubMed ID: 8914744
[TBL] [Abstract][Full Text] [Related]
35. Genetic and molecular aspects of acromelic dysplasia.
Le Goff C; Cormier-Daire V
Pediatr Endocrinol Rev; 2009 Mar; 6(3):418-23. PubMed ID: 19396027
[TBL] [Abstract][Full Text] [Related]
36. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome.
Dagoneau N; Benoist-Lasselin C; Huber C; Faivre L; Mégarbané A; Alswaid A; Dollfus H; Alembik Y; Munnich A; Legeai-Mallet L; Cormier-Daire V
Am J Hum Genet; 2004 Nov; 75(5):801-6. PubMed ID: 15368195
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.
Le Goff C; Mahaut C; Wang LW; Allali S; Abhyankar A; Jensen S; Zylberberg L; Collod-Beroud G; Bonnet D; Alanay Y; Brady AF; Cordier MP; Devriendt K; Genevieve D; Kiper PÖ; Kitoh H; Krakow D; Lynch SA; Le Merrer M; Mégarbane A; Mortier G; Odent S; Polak M; Rohrbach M; Sillence D; Stolte-Dijkstra I; Superti-Furga A; Rimoin DL; Topouchian V; Unger S; Zabel B; Bole-Feysot C; Nitschke P; Handford P; Casanova JL; Boileau C; Apte SS; Munnich A; Cormier-Daire V
Am J Hum Genet; 2011 Jul; 89(1):7-14. PubMed ID: 21683322
[TBL] [Abstract][Full Text] [Related]
38. Separation in genetic pathogenesis of mutations in FBN1-TB5 region between autosomal dominant acromelic dysplasia and Marfan syndrome.
Sun C; Xu D; Pei Z; Yang L; Qiao Z; Lu W; Luo F; Qiu Z
Birth Defects Res; 2020 Dec; 112(20):1834-1842. PubMed ID: 33030311
[TBL] [Abstract][Full Text] [Related]
39. Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease.
Hubmacher D; Schneider M; Berardinelli SJ; Takeuchi H; Willard B; Reinhardt DP; Haltiwanger RS; Apte SS
Sci Rep; 2017 Feb; 7():41871. PubMed ID: 28176809
[TBL] [Abstract][Full Text] [Related]
40. ADAMTS proteins as modulators of microfibril formation and function.
Hubmacher D; Apte SS
Matrix Biol; 2015 Sep; 47():34-43. PubMed ID: 25957949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
